<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04902222</url>
  </required_header>
  <id_info>
    <org_study_id>H-20071567</org_study_id>
    <nct_id>NCT04902222</nct_id>
  </id_info>
  <brief_title>Orthostatic Intolerance and Hypotension After Administration of Morphine in Patients Prior to Hip or Knee Arthroplasty</brief_title>
  <official_title>Incidence of Orthostatic Intolerance and Orthostatic Hypotension After Administration of Intravenous Morphine in Patients Prior to Hip or Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Copenhagen University Hospital, Hvidovre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Henrik Kehlet</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Copenhagen University Hospital, Hvidovre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Incidence of orthostatic intolerance and orthostatic hypotension after intravenous&#xD;
      administration of morphine in patients prior to hip or knee arthroplasty.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Early postoperative mobilization is crucial for recovery of patients undergoing surgery in&#xD;
      the multimodal fast-track approach to perioperative care, since physical immobilization is&#xD;
      highly associated with increased risk of postoperative complications and prolonged hospital&#xD;
      length of stay. Postoperative mobilization is often delayed due to patients experiencing&#xD;
      orthostatic hypotension (OH), defined as a drop in systolic blood pressure &gt; 20 mmHg or&#xD;
      diastolic blood pressure &gt; 10 mmHg, or orthostatic intolerance (OI), characterized by&#xD;
      dizziness, blurred vision, nausea, vomiting, sensation of heat or syncope.&#xD;
&#xD;
      Previous studies have found a high incidence of postoperative OI (&gt; 40 %) among patients&#xD;
      undergoing total hip arthroplasty.&#xD;
&#xD;
      A possible causative factor to the high occurrence of OH and OI after surgery could be&#xD;
      postoperative pain management by administration of morphine. Morphine is known to have many&#xD;
      side-effects including nausea, vomiting, dizziness and orthostatic hypotension.&#xD;
&#xD;
      The object of this study is to isolate and estimate the effect of intravenous morphine on the&#xD;
      incidence of OH and OI.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2021</start_date>
  <completion_date type="Anticipated">May 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of orthostatic hypotension</measure>
    <time_frame>30 minutes after morphine administration</time_frame>
    <description>Orthostatic hypotension is defined as a fall in systolic pressure &gt; 20 mmHg and/or diastolic pressure &gt; 10 mmHg during mobilization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in systolic arterial pressure (SAP) during mobilization</measure>
    <time_frame>Before and 30 minutes after morphine administration</time_frame>
    <description>Measured in mmHg by non-invasive Lithium Dilution Cardiac Output (LiDCO) measurement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in diastolic arterial pressure (DAP) during mobilization</measure>
    <time_frame>Before and 30 minutes after morphine administration</time_frame>
    <description>Measured in mmHg by non-invasive LiDCO</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in mean arterial pressure (MAP) during mobilization</measure>
    <time_frame>Before and 30 minutes after morphine administration</time_frame>
    <description>Measured in mmHg by non-invasive LiDCO</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in heart rate (HR) during mobilization</measure>
    <time_frame>Before and 30 minutes after morphine administration</time_frame>
    <description>Measured in beats min-1 by non-invasive LiDCO</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in stroke volume (SV) during mobilization</measure>
    <time_frame>Before and 30 minutes after morphine administration</time_frame>
    <description>Measured in mL by non-invasive LiDCO</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in cardiac output (CO) during mobilization</measure>
    <time_frame>Before and 30 minutes after morphine administration</time_frame>
    <description>Measured in L/min by non-invasive LiDCO</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in systemic vascular resistance (SVR) during mobilization</measure>
    <time_frame>Before and 30 minutes after morphine administration</time_frame>
    <description>Measured in dynes s cm-5 by non-invasive LiDCO</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in peripheral perfusion index (PPI) during mobilization</measure>
    <time_frame>Before and 30 minutes after morphine administration</time_frame>
    <description>Measured in % by Root Masimo</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in cerebral perfusion (ScO2) during mobilization</measure>
    <time_frame>Before and 30 minutes after morphine administration</time_frame>
    <description>Measured in % by Root Masimo</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in muscular perfusion (SmO2) during mobilization</measure>
    <time_frame>Before and 30 minutes after morphine administration</time_frame>
    <description>Measured in % by Root Masimo</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in baroreflex sensitivity - vagal (BRSv) during Valsalva manoeuvre</measure>
    <time_frame>Before and 30 minutes after morphine administration</time_frame>
    <description>Measured in ms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in heart rate variability (HRV) during Valsalva manoeuvre</measure>
    <time_frame>Before and 30 minutes after morphine administration</time_frame>
    <description>Measured in ms</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Pain score during mobilisation</measure>
    <time_frame>Before and 30 minutes after morphine administration</time_frame>
    <description>Measured by verbal rating scale (VRS) from 0 to 10 (0 = no pain, 10 = worse pain imaginable)</description>
  </other_outcome>
  <other_outcome>
    <measure>Occurence of side-effects to morphine administration</measure>
    <time_frame>30 minutes after morphine administration</time_frame>
    <description>Occurrence of following side-effects to morphine administration: nausea, vomiting, pruritus, headache or dizziness</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">26</enrollment>
  <condition>Orthostatic Hypotension</condition>
  <condition>Orthostatic Intolerance</condition>
  <arm_group>
    <arm_group_label>Patients undergoing primary hip or knee arthroplasty</arm_group_label>
    <description>Patients undergoing primary hip or knee arthroplasty</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine</intervention_name>
    <description>Administration of 0.1 mg/kg (IBW) intravenous morphine</description>
    <arm_group_label>Patients undergoing primary hip or knee arthroplasty</arm_group_label>
    <other_name>opioid</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing primary unilateral total hip arthroplasty, total knee arthroplasty or&#xD;
        unicompartmental knee arthroplasty&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing primary unilateral total hip arthroplasty (THA), total knee&#xD;
             arthroplasty (TKA) or unicompartmental knee arthroplasty (UKA)&#xD;
&#xD;
          -  Patients &gt; 18&#xD;
&#xD;
          -  Patients that understand and speak Danish&#xD;
&#xD;
          -  Patients that have provided written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Alcohol or substance abuse&#xD;
&#xD;
          -  Habitual use of opioids&#xD;
&#xD;
          -  Habitual use of anxiolytic, antidepressant and/or antipsychotic drugs&#xD;
&#xD;
          -  History of previous orthostatic intolerance or hypotension&#xD;
&#xD;
          -  Cognitive dysfunction&#xD;
&#xD;
          -  Glomerular filtration rate (GFR) &lt; 30 ml/min&#xD;
&#xD;
          -  Cardiac arrhythmia&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Nicolai Bang Foss, Dr. Med.</last_name>
    <role>Study Director</role>
    <affiliation>Copenhagen University Hospital, Hvidovre</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bodil Uldall-Hansen, BA Medicine</last_name>
    <phone>+4528342057</phone>
    <email>bodil.uldall-hansen@regionh.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ana-Marija Hristovska, Resident</last_name>
    <phone>+4538621508</phone>
    <email>anamarijahristovska@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hvidovre University Hospital</name>
      <address>
        <city>Hvidovre</city>
        <zip>2960</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bodil Uldall-Hansen, BA Medicine</last_name>
      <phone>+4528342057</phone>
      <email>bodil.uldall-hansen@regionh.dk</email>
    </contact>
    <contact_backup>
      <last_name>Ana-Marija Hristovska, Resident</last_name>
      <phone>+4538621508</phone>
      <email>anamarijahristovska@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>May 20, 2021</study_first_submitted>
  <study_first_submitted_qc>May 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 26, 2021</study_first_posted>
  <last_update_submitted>June 15, 2021</last_update_submitted>
  <last_update_submitted_qc>June 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Copenhagen University Hospital, Hvidovre</investigator_affiliation>
    <investigator_full_name>Bodil Uldall-Hansen</investigator_full_name>
    <investigator_title>Research assistant</investigator_title>
  </responsible_party>
  <keyword>Orthostatic Hypotension</keyword>
  <keyword>Orthostatic Intolerance</keyword>
  <keyword>Morphine</keyword>
  <keyword>Autonomic Dysfunction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypotension, Orthostatic</mesh_term>
    <mesh_term>Orthostatic Intolerance</mesh_term>
    <mesh_term>Hypotension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

